Kestra Medical reports Q4 revenue $28.6M (+66% YoY); secures $200M loan facility

KESTRA MEDICAL TECHNOLOGIES, LTD.

Q4 FY2026 revenue $28.6M (+66% YoY); FY revenue $95.1M (+59% YoY); FY27 guidance $137M (+44%).
Gross margin expanded to 54.8% in Q4 (vs 44.3% prior year); FY margin 51.4% (vs 40.5%).
GAAP net loss Q4 $38.8M, FY $131.6M; adjusted EBITDA loss Q4 $26.7M, FY $87.0M.
Entered $200M senior secured loan facility; drew $75M Tranche A on July 10, 2026; net proceeds ~$20M after repaying prior loan.
Loan matures July 10, 2031; interest SOFR+5.50% (floor 3.25%); 48 months interest-only; minimum liquidity $20M.

item 1.01 item 1.02 item 2.02 item 2.03 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.